Related Experiment Video

Updated: May 28, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Loss of RKIP expression during the carcinogenic evolution of endometrial cancer

Olga Martinho1, Carlos Chaves Faloppa, Cristovam Scapulatempo Neto

  • 1Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal.

Journal of Clinical Pathology
|October 28, 2011
PubMed
Abstract

Insights

Raf kinase inhibitory protein (RKIP) is highly expressed in normal endometrial tissues but significantly decreases in endometrial cancer. Loss of RKIP is linked to a malignant phenotype, highlighting its potential role in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Endometrial cancer lacks early diagnostic markers.
  • Raf kinase inhibitory protein (RKIP) is a negative regulator of the Raf/MEK/ERK pathway.
  • RKIP downregulation correlates with tumor progression and metastasis in various cancers.

Purpose of the Study:

  • To assess RKIP expression levels in endometrial cancer.
  • To determine the correlation between RKIP expression and clinical outcomes in endometrial cancer patients.

Main Methods:

  • Immunohistochemistry was used to analyze RKIP expression.
  • Tissue microarrays from 209 endometrial adenocarcinomas, 49 polyps, and 48 hyperplasias were studied.

Main Results:

  • RKIP expression significantly decreases during endometrial cancer progression.
  • High RKIP expression was observed in polyps (79.6%) and hyperplasias (87.5%).
  • Low RKIP expression was found in endometrioid adenocarcinomas (29.7%).

Conclusions:

  • RKIP expression is lost during endometrial tumor carcinogenesis.
  • Loss of RKIP expression is associated with a malignant endometrial phenotype.
  • Further functional studies are required to elucidate the biological role of RKIP in endometrial cancer.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...